Conditions: Diabetic Nephropathy Type 2 Diabetes Mellitus Proteinuria
Keywords: angiotensin II type I receptor blockers diabetic nephropathy end-stage renal disease renal failure type 2 diabetes olmesartan medoxomil
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 577
Healthy volunteers: no

Brief summary:
The purpose of the study is to evaluate the effectiveness and safety of olmesartan versus placebo on the progression of diabetic renal disease.

Detailed description:

Arms:
arm 1: Olmesartan medoxomil tablets 10mg to 40 mg arm 2: Matching placebo tablets

Interventions: intervention 1: olmesartan medoxomil intervention 2: Placebo Tablets
Intervention descriptions: intervention 1: Tablets 10, 20, or 40 mg intervention 2: Matching placebo tablets

Protocol document: